May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia?

Abstract

INTRODUCTION The treatment of some psychopathological dimensions of schizophrenia (e.g. negative and depressive symptoms) is still challenging for the modest efficacy of atypical antipsychotics. Among pharmacological alternatives, augmentative Selective Serotonin Reuptake Inhibitors (SSRIs) to antipsychotics are frequently prescribed in clinical practice to… (More)
DOI: 10.1080/14656566.2016.1186646

Topics

Cite this paper

@article{Buoli2016MaySS, title={May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia?}, author={Massimiliano Buoli and Marta Serati and Valentina Ciappolino and Antonio Altamura}, journal={Expert opinion on pharmacotherapy}, year={2016}, volume={17 10}, pages={1375-85} }